268 related articles for article (PubMed ID: 37339976)
1. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.
de Rus Jacquet A; Alpaugh M; Denis HL; Tancredi JL; Boutin M; Decaestecker J; Beauparlant C; Herrmann L; Saint-Pierre M; Parent M; Droit A; Breton S; Cicchetti F
Nat Commun; 2023 Jun; 14(1):3651. PubMed ID: 37339976
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease.
Lan G; Wang P; Chan RB; Liu Z; Yu Z; Liu X; Yang Y; Zhang J
Glia; 2022 Feb; 70(2):337-353. PubMed ID: 34713920
[TBL] [Abstract][Full Text] [Related]
3. [Research progress on neural mechanism of peripheral inflammation in Parkinson's disease].
Liu YT; Sun MH; Cai CW; Ren C; Niu HC
Sheng Li Xue Bao; 2019 Oct; 71(5):732-740. PubMed ID: 31646327
[TBL] [Abstract][Full Text] [Related]
4. Small heterodimer partner (SHP) aggravates ER stress in Parkinson's disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation.
Lee JH; Han JH; Joe EH; Jou I
J Biomed Sci; 2021 Jul; 28(1):51. PubMed ID: 34229656
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
6. String Vessel Formation is Increased in the Brain of Parkinson Disease.
Yang P; Pavlovic D; Waldvogel H; Dragunow M; Synek B; Turner C; Faull R; Guan J
J Parkinsons Dis; 2015; 5(4):821-36. PubMed ID: 26444086
[TBL] [Abstract][Full Text] [Related]
7. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.
Cai P; Zheng Y; Sun Y; Zhang C; Zhang Q; Liu Q
ACS Chem Neurosci; 2021 Oct; 12(20):3829-3837. PubMed ID: 34623131
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches.
Khor SLQ; Ng KY; Koh RY; Chye SM
CNS Neurol Disord Drug Targets; 2024; 23(3):315-330. PubMed ID: 36999187
[TBL] [Abstract][Full Text] [Related]
9. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.
Neal ML; Boyle AM; Budge KM; Safadi FF; Richardson JR
J Neuroinflammation; 2018 Mar; 15(1):73. PubMed ID: 29519253
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
11. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology.
Prunell G; Olivera-Bravo S
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551173
[TBL] [Abstract][Full Text] [Related]
12. Metabolic alterations in Parkinson's disease astrocytes.
Sonninen TM; Hämäläinen RH; Koskuvi M; Oksanen M; Shakirzyanova A; Wojciechowski S; Puttonen K; Naumenko N; Goldsteins G; Laham-Karam N; Lehtonen M; Tavi P; Koistinaho J; Lehtonen Š
Sci Rep; 2020 Sep; 10(1):14474. PubMed ID: 32879386
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
[TBL] [Abstract][Full Text] [Related]
14. Glial reactions in Parkinson's disease.
McGeer PL; McGeer EG
Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
[TBL] [Abstract][Full Text] [Related]
15. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review).
Wang H; Liu Y; Zhao J; Guo X; Hu M; Chen Y
Clin Neurol Neurosurg; 2021 Sep; 208():106844. PubMed ID: 34388595
[TBL] [Abstract][Full Text] [Related]
16. Intranigral Administration of
Luna-Herrera C; Martínez-Dávila IA; Soto-Rojas LO; Flores-Martinez YM; Fernandez-Parrilla MA; Ayala-Davila J; León-Chavez BA; Soto-Rodriguez G; Blanco-Alvarez VM; Lopez-Salas FE; Gutierrez-Castillo ME; Gatica-Garcia B; Padilla-Viveros A; Bañuelos C; Reyes-Corona D; Espadas-Alvarez AJ; Garcés-Ramírez L; Hidalgo-Alegria O; De La Cruz-López F; Martinez-Fong D
J Immunol Res; 2020; 2020():5907591. PubMed ID: 33282962
[TBL] [Abstract][Full Text] [Related]
17. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
[TBL] [Abstract][Full Text] [Related]
18. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes.
Booth HDE; Wessely F; Connor-Robson N; Rinaldi F; Vowles J; Browne C; Evetts SG; Hu MT; Cowley SA; Webber C; Wade-Martins R
Neurobiol Dis; 2019 Sep; 129():56-66. PubMed ID: 31085228
[TBL] [Abstract][Full Text] [Related]
20. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
